Dec 10, 2024 | Genomics, Nutrigenomics, Weight loss, Weight management
Nutrigenomic testing, available through MedBen Rx, analyzes an individual’s genetic makeup to understand how their genes influence their response to nutrition, diet, and lifestyle factors. As the list below shows, the wealth of information uncovered through...
Jun 10, 2024 | Affordable Care Act, Caroline Fraker, Wegovy, Weight loss, Weight loss drugs, Zepbound
While most health plans do not currently cover obesity medications like Wegovy and Zepbound – and MedBen Rx recommends clients continue not to do so – constant media coverage means the calls to do so will only grow. Therefore, employers are increasingly considering...
May 13, 2024 | Diabetes, Kurt Harden, MedBen University, Mounjaro, Ozempic, Wegovy, Weight loss, Zepbound
At recent MedBen University roundtables, MedBen President & CEO Kurt Harden examined how the growing public awareness of two diabetes drugs with a desirable side effect – significant weight loss – means that these $1,000-per-month medications are not always being...
Sep 18, 2023 | Announcements, Diabetes, MedBen Rx, Ozempic, Weight loss
Important information for MedBen Rx clients using the Ventegra formulary: Effective October 1, an appropriate ICD-10 diagnosis code for type 2 diabetes will be required for certain Ozempic prescriptions and all other GLP-1 class medications. Ozempic and other GLP-1...
